Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data

Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data

Abstract Background In January 2021, the United States (US) Food and Drug Administration (FDA) approved the first long-acting injectable antiretroviral therapy (LAI ART) regimen for the treatment of HIV providing an alternative to daily oral regimens. We analyzed electronic health records (EHRs) to...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiyang Liu, Rebecca J. Fisk-Hoffman, Maitri Patel, Robert L. Cook, Mattia Prosperi
Format: Article
Language:English
Published: BMC 2025-02-01
Series:AIDS Research and Therapy
Subjects:
HIV
Long-acting antiretroviral therapy
Electronic health records
Cabotegravir/Rilpivirine
Online Access:https://doi.org/10.1186/s12981-024-00690-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12981-024-00690-9

Similar Items